Launch of HIV medication, Lenacapavir to be held on Friday President Cyril Ramaphosa is expected to launch the roll out of the lifesaving HIV prevention injectable medicine, Lenacapavir, later this ...
It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South ...
Lenacapavir, an injectable drug for HIV prevention, is praised as a potential game-changer and offers hope for those who find daily oral medications challenging. The drug requires administration only ...
The claim: New $40,000 twice yearly shot is 'AIDS cure' A Dec. 2 Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed for a ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...
HIV treatment has been improved and simplified significantly over the years, yet a small fraction of people living with HIV ...
A newly approved drug gives almost total protection against getting HIV. The FDA approved lenacapavir last week. Patients need just two injections of it a year to get that protection, but as NPR's ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...
Please provide your email address to receive an email when new articles are posted on . New WHO guidelines recommend the use of twice-yearly lenacapavir and rapid diagnostic tests. Gilead and the ...